P467 The impact of elexacaftor/tezacaftor/ivacaftor on physical activity and physiotherapy adherence among people with cystic fibrosis – a single center experience von Vogiatzis, M., Kanli, A., Peftoulidou, P., Chrysochoou, E.-A., Sopiadou, A., Kyrvassili, E., Hristara, A., Hatziagorou, E.

Volltext

ePS2.04 Is tele-physiotherapy as effective as home-visit-guided physiotherapy among children with cystic fibrosis? von Peftoulidou, P., Mouratidou, I.-C., Chrysochoou, E.-A., Gioulvanidou, M., Galogavrou, M., Hristara, A., Hatziagorou, E.

Volltext

EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis von Hatziagorou, E., Peftoulidou, P., Toulia, I., Tasika, E., Chrysochoou, E.-A., Tsanakas, J.

Volltext

P121 Short-term effect of physiotherapy on Lung Clearance Index among patients with cystic fibrosis von Kouroukli, E., Hatziagorou, E., Parisi, M., Peftoulidou, P., Mouratidou, I.-C., Tsanakas, J.

Volltext

Phenytoin plasma levels after intraoperative administration, for the prevention of post-craniotomy seizures von TSOLAKI, M, YANNACOU-PEFTOULIDOU, M, GRAMMATICOS, P, SOFIANOS, E, FOROGLOU, G

Volltext